19.08.2015
- US biopharmaceutical company Aveo Oncology has entered into a global license agreement with Novartis for its AV-380 and related antibodies. AV-380 is a potent inhibitory antibody...
28.10.2013
- Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...
15.08.2013
- Russian drugmaker Pharmstandard has agreed to buy a supplier of ingredients for its flagship anti-viral and anxiety drugs for $590 million, as part of a plan to spin off its over...
09.07.2013
- Pharmstandard, Russia's leading drugmaker has started steps to spin off its over-the-counter medicines business, it said on Monday. The Russian company, majority owned by...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
